Ingevity (NYSE: NGVT) is one of 33 public companies in the “Commodity Chemicals” industry, but how does it contrast to its competitors? We will compare Ingevity to related businesses based on the strength of its institutional ownership, dividends, valuation, earnings, profitability, analyst recommendations and risk.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Ingevity and its competitors, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ingevity 0 0 6 0 3.00
Ingevity Competitors 108 837 1232 36 2.54

Ingevity presently has a consensus price target of $76.00, suggesting a potential upside of 4.94%. As a group, “Commodity Chemicals” companies have a potential downside of 3.70%. Given Ingevity’s stronger consensus rating and higher possible upside, research analysts plainly believe Ingevity is more favorable than its competitors.


This table compares Ingevity and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ingevity 9.86% 58.14% 12.09%
Ingevity Competitors -29.43% 23.88% 5.57%

Earnings and Valuation

This table compares Ingevity and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ingevity $908.30 million $35.20 million 32.62
Ingevity Competitors $4.01 billion $340.26 million 138.42

Ingevity’s competitors have higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Ingevity has a beta of 1.78, suggesting that its share price is 78% more volatile than the S&P 500. Comparatively, Ingevity’s competitors have a beta of 1.20, suggesting that their average share price is 20% more volatile than the S&P 500.

Institutional & Insider Ownership

91.4% of Ingevity shares are held by institutional investors. Comparatively, 70.9% of shares of all “Commodity Chemicals” companies are held by institutional investors. 0.1% of Ingevity shares are held by insiders. Comparatively, 7.8% of shares of all “Commodity Chemicals” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.


Ingevity beats its competitors on 8 of the 13 factors compared.

About Ingevity

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals. The Performance Materials segment primarily produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Performance Chemicals segment develops, manufactures and sells a range of specialty chemicals primarily derived from co-products of the Kraft pulping process. Its products are used in a range of applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks and automotive components that reduce gasoline vapor emissions.

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with's FREE daily email newsletter.